University Hospital Leipzig, Department for Neurology and Neurosurgery
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Weise, David
ADOPTION, NCT04990284 / 2020-002754-24: eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

Active, not recruiting
4
106
Europe
Opicapone, BIA 9-1067, L-DOPA/DDCI, Levodopa
Bial - Portela C S.A., Bial - Portela & Ca, S.A.
Parkinson Disease
06/23
06/23
TEMPO-3, NCT04542499 / 2019-002951-40: Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations

Completed
3
507
Europe, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
01/24
02/24
TEMPO-1, NCT04201093 / 2019-002949-38: Fixed-Dose Trial in Early Parkinson's Disease (PD)

Completed
3
522
Europe, Canada, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
06/24
06/24
ORION, NCT06122662: AMX0035 and Progressive Supranuclear Palsy

Active, not recruiting
2/3
110
Europe, US
AMX0035, Placebo
Amylyx Pharmaceuticals Inc.
Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases, Atypical Parkinsonism
04/26
11/29
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies

Recruiting
N/A
200
Europe, Japan, RoW
Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona
Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy
12/23
07/24

Download Options